SEARCH
Vulnerable Covid patients to be given GSK's antibody drug on the NHS 'that can fight Omicron' - 1br
1BN-RADIO
2021-12-21
Views
6
Description
Share / Embed
Download This Video
Report
Xevudy, made by British pharmaceutical giant GlaxoSmithKline, was shown to slash the risk of hospitalisation and death by 79 per cent in clinical trials.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x86gq22" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
06:16
How Omicron Evades Natural Immunity, Vaccination, And Monoclonal Antibody Treatments - 1breakingnews
02:14
New Omicron subvariant resistant to all antibody therapies: Indian-origin scientist - 1breakingnews.
04:35
Moderna booster shots: Biden to kick off campaign for 100 million eligible boosters as omicron - 1br
03:14
Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines - 1breakingnews
03:24
NIH: COVID-19 booster-induced antibody response to omicron significantly decreases over time - 1brea
00:44
Moderna: Booster Shot Increases Omicron Antibodies
02:24
Moderna booster shot increases antibody levels against Omicron, company says - 1breakingnews.com
01:30
Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says
01:31
Moderna Says Their Booster Shot Raises Level of Antibodies Against Omicron
06:06
NHS hospitals draw up Omicron battle plans to plug depleted workforces as data shows the numbe - 1br
01:54
NHS plans to set up 'mini Nightingales' to tackle Omicron surge: Hospital canteens, car parks - 1br
04:28
Boosters for the vulnerable could be key against Omicron